Mkts

Ginkgo Bioworks Holdings, Inc.

NYSE: DNA
$7.46-0.74 (-9.02%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
7.388.29
52-week range
5.3718.22
Today
Open7.93
Previous close7.46
Volume—
Valuation
Market cap483.59M
P/E ratio—
EPS (TTM)-5.00
Income & risk
Dividend / yield—
Beta1.85
Avg volume2.08M
Discussion

DNA News

Stories mentioning DNA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue19,47443,48438,83749,60438,23043,84789,04656,206
Cost of Goods Sold3,0984,090
Gross Profit16,37634,140
Operating Expenses
Research & Development49,92050,12769,35353,37070,92376,37777,006134,221
Sales General & Admin
Total Operating Expenses104,148128,854115,145137,286147,453144,250279,151
Operating Income (Loss)(71,374)(78,748)(90,017)(65,541)(80,972)(103,606)(55,204)(222,945)
Interest Income
Interest Expense
Other Expense(4,765)(10,293)9,2634,958(2,250)(4,253)(1,574)5,954
Pretax Income(76,139)(89,041)(80,754)(60,583)(83,222)(107,859)(56,778)(216,991)
Tax Provision(80.00)(643.00)1.00(283.00)88.00(325.00)(375.00)190.00
Net Income (Loss)(82,587)(80,755)(90,957)(56,403)(217,181)
Earnings Per Share (Basic)(1.39)0.00(1.45)(1.10)(1.68)0.00(1.08)(4.23)
Earnings Per Share (Diluted)0.00(1.45)(1.10)(1.68)0.00(1.08)(4.23)
Weighted Average Shares Outstanding (Basic)59,56355,45855,63454,85954,24251,89552,24151,370
Weighted Average Shares Outstanding (Diluted)55,45855,63454,85954,24251,89552,24651,376

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About DNA

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a stock listed on the New York Stock Exchange under the ticker symbol DNA. It last traded at $7.46 (Nov 20, 2026, 4:00 PM ET), down 9.0% on the day. That gives Ginkgo Bioworks a market capitalisation of $483.6M.

Over the past 52 weeks DNA has traded between $5.37 and $18.22.

Revenue for the quarter ended Mar 31, 2026 was $19.5M; a net loss of $82.6M. Revenue was down 49.1% from $38.2M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$19.5M-$82.6M-424.1%
Dec 31, 2025$43.5M——
Sep 30, 2025$38.8M-$80.8M-207.9%
Jun 30, 2025$49.6M——

From Ginkgo Bioworks’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…